Neuroglee Therapeutics
Signal active
Organization
Contact Information
Overview
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.
About
Industries
Biotechnology, Life Science
Founded
2020
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
Neuroglee Therapeutics headquartered in Asia, operates in the Biotechnology, Life Science sector. The company focuses on Biotechnology and has secured $196.8M in funding across 16 round(s). With a team of 11-50 employees, Neuroglee Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Neuroglee Therapeutics, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
6
Lead Investors
0
Total Funding Amount
$12.3M
Details
2
Neuroglee Therapeutics has raised a total of $12.3M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 2.3M | ||
| 2021 | Early Stage Venture | 10.0M |
Investors
Neuroglee Therapeutics is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Wendou Niu | - | FUNDING ROUND - Wendou Niu | 10.0M |
| Shane Chesson | - | FUNDING ROUND - Shane Chesson | 10.0M |
| Neuroglee Therapeutics | - | FUNDING ROUND - Neuroglee Therapeutics | 10.0M |
| Openspace | - | FUNDING ROUND - Openspace | 10.0M |
Recent Activity
There is no recent news or activity for this profile.